|
General Information
|
Capital city
Number of islands
Land area
Language
Ethinicity
GNP per capita
Economy
|
Port Vila
80
12,190 sq km
Local languages, Bislama, English, French
Melanesian
US$1,270
Agriculture, fishing, forest products, tourism |
Total population by census (1999)
Population estimated (2000)
Male/Female
Population growth rate
Population density
Life expectancy at birth |
193,219
199,800
105/100
3.0%
16 sq km
62.8 |
| Mortality: Diseases of the circulatory system, malignant neoplasms, bronchitis, emphysema & asthma |
|
POPULATION
|
WEATHER
|
 |
 |
History of Filariasis Prevalence
| Year |
Study Group |
Symptoms |
Prevalence |
| 1927 |
Males, >12 from 16 Islands |
Elephantiasis |
19% |
|
|
Hydrocele |
23% |
|
|
palpable epitrochlear glands |
53% |
| There is no history of MDA campaign having been carried out in Vanuatu. |
| PacELF Activities carried out to date: |
| • |
Blood survey |
 |
| • |
MDA (DEC 6mg/kg + Albendazole 400mg) |
| • |
Mass media campaign |
| • |
Health education |
| • |
Workshops |
| • |
Vector control |
| • |
Helminth survey |
| Filaria Type |
Wuchereria bancrofti, Noctunally periodic |
| Mosquito vectors |
Anopheles farauti |
| Filariasis latest status |
Endemic |
| Operational Staff |
Malaria and VBDU |
| Partnership |
JICA (DEC and ICT), GSK (Albendazole), JOCV (Volunteer), Liverpool School Tropical Medicine (VSO Volunteer) |
Results of blood surveys carried out under PacELF Programme
|
Date
|
Test Method
|
Target
|
Sampling Method
|
No. of examined
|
No. of positives
|
Positive rate(%)
|
|
1997-1998
|
ICT
|
Whole area (6 provinces)
|
Convenience
|
4362
|
209
|
4.79
|
|
1997-1998
|
MF
|
Whole area (6 provinces)
|
Convenience
|
4269
|
106
|
2.48
|
|
2002
|
ICT
|
Sentinel sites + other areas)
|
Convenience
|
1940
|
155
|
7.99
|
|
2002
|
MF
|
Sentinel sites + other areas)
|
Convenience
|
1940
|
23
|
1.19
|
| 2003 |
ICT |
Sentinel sites + other areas) |
Convenience |
629 |
52 |
8.3 |
| 2004 |
ICT |
Spot check site (Ambrym) |
Convenience |
538 |
106 |
19.7 |
| 2005 |
ICT |
Whole area |
Stratified cluster sampling |
7576 |
18 |
0.24 |
Results of MDAs carried out under PacELF Programme
| Year |
MDA |
Reported Population |
Registered
Population
|
% Registered
|
Treated Population
|
%Treated/
Reported
|
%Treated/
Registered
|
|
2000
|
1st |
186678
|
196210
|
105.11 |
154739 |
82.89 |
78.86 |
| 2001 |
2nd |
186678 |
188132 |
100.78 |
156368 |
83.76 |
83.12 |
| 2002 |
3rd |
186678 |
183779 |
98.45 |
156350 |
83.75 |
85.08 |
| 2003 |
4th |
186678 |
196400 |
105.21 |
163271 |
87.46 |
83.13 |
| 2004 |
5th |
186678 |
|
|
158758 |
85.04 |
|
|
Contact:
|
|
Mrs Fasihah Taleo,
National Officer, Lymphatic Filariasis Mass Drug Administration Coordinator,
P.M.B 009, Malaria Section, Health Department, Port Vila, Vanuatu.
Tel: (678) 25171 Fax: (678) 26204
E-mail: vbd2@vanuatu.gov.vu
|
|
